An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa.

ABSTRACT:

Introduction

Past endeavours to deal with the obstacle of expensive Cluster of Difference 4 (CD4⁺) count diagnostics in resource-limited settings have left a long trail of suggested continuous CD4⁺ count clinical covariates that turned out to be a potentially important integral part of the human immunodeficiency virus (HIV) treatment process during disease progression. However, an evaluation to determine the strongest candidates among these CD4⁺ count covariates has not been well documented.

Methods

The Centre for the AIDS Programme of Research in South Africa (CAPRISA) initially enrolled HIV-negative (phase 1) patients into different study cohorts. The patients who seroconverted (237) during follow-up care were enrolled again into a post-HIV

SUBMITTER: Tinarwo P 

PROVIDER: S-EPMC6522572 | biostudies-literature | 2019 Jun

REPOSITORIES: biostudies-literature